# Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery

> **NCT05624424** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 1317 (estimated)

## Conditions studied

- Emergence Agitation
- Remimazolam Besylate
- Perioperative Sedation
- Laparoscopic Abdominal Surgery
- Anesthesia, General

## Interventions

- **DRUG:** Rematazolam Besylate
- **DRUG:** Propofol
- **DRUG:** Sevoflurane
- **DRUG:** Sufentanil
- **DRUG:** Cisatracurium Besylate
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT05624424
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-15
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 1317 (ESTIMATED)
- **Last updated:** 2022-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05624424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05624424, "Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05624424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*